Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.

Journal Article (Journal Article;Review)

Savient Pharmaceuticals Inc (formerly Bio-Technology General Corp), under license from Duke University, is developing pegloticase, PEG conjugates of uricase (urate oxidase), for the potential treatment of gout. The in-life portion of the phase III trials have been completed.

Full Text

Duke Authors

Cited Authors

  • Biggers, K; Scheinfeld, N

Published Date

  • April 2008

Published In

Volume / Issue

  • 9 / 4

Start / End Page

  • 422 - 429

PubMed ID

  • 18393109

International Standard Serial Number (ISSN)

  • 1472-4472


  • eng

Conference Location

  • England